The abnormal expression of miR-105 in EV is the result of the MYC oncoprotein in BC cells and in turn, acts on MXI1 in CAFs and activates MYC signaling to induce a metabolic program that is suitable for tumor growth. Here, MYC is linked to neoplasm.